Your browser doesn't support javascript.
loading
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms.
Patnaik, Mrinal M; Zeidan, Amer M; Padron, Eric; Platzbecker, Uwe; Sallman, David A; DeZern, Amy E; Bejar, Rafael; Sekeres, Mikkael; Taylor, Justin; Little, Richard F; Bewersdorf, Jan P; Kim, Tae Kon; Kim, Nina; Hourigan, Christopher S; Dela Porta, Matteo G; Stahl, Maximilian; Steensma, David; Xu, Mina L; Odenike, Olatoyosi; Carraway, Hetty; Fenaux, Pierre; Nazha, Aziz; Komrokji, Rami; Loghavi, Sanam; Xie, Zhuoer; Hasserjian, Robert; Savona, Michael; Bennett, John M.
Afiliação
  • Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. Patnaik.mrinal@mayo.edu.
  • Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Padron E; Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
  • Platzbecker U; Department of Hematology, University of Leipzig, Leipzig, Germany.
  • Sallman DA; Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
  • DeZern AE; Division of Hematologic Malignancies; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
  • Bejar R; Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, USA.
  • Sekeres M; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Taylor J; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Little RF; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kim TK; Division of Hematology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Kim N; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Hourigan CS; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Dela Porta MG; Humanitas Clinical and Research Center & Humanitas University, Department of Biomedical Sciences, Milan, Italy.
  • Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Steensma D; Novartis Institute of Blood Research, Boston, MA, USA.
  • Xu ML; Departments of Pathology & Laboratory Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Odenike O; Section of Hematology/Oncology, the University of Chicago Medicine, Chicago, IL, USA.
  • Carraway H; Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Fenaux P; Hôpital St Louis, Assistance Publique Hôpitaux de Paris, and Université Paris Cité, Paris, France.
  • Nazha A; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Komrokji R; Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
  • Loghavi S; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Xie Z; Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
  • Hasserjian R; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Savona M; Division of Hematology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Bennett JM; Department of Medicine, Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Leukemia ; 36(12): 2934-2938, 2022 12.
Article em En | MEDLINE | ID: mdl-36335264

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Mieloproliferativas-Mielodisplásicas / Transtornos Mieloproliferativos / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Mieloproliferativas-Mielodisplásicas / Transtornos Mieloproliferativos / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article